A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases

Clinical trial NCT00969410 · COMPLETED

Trial details

NCT number: NCT00969410
Sponsor: AVEO Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumour Liver Metastases

Start date: 2009-08-01
Primary completion: 2011-03-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.